ChemBK
Home
Product Category
Suppliers
Search
Cyclopentanecarboxylic acid, 3-[(1R)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-rel-
Request for Quotation
Peramivir Impurity 6
CAS: 2124296-37-1
Molecular Formula: C15H28N4O4
Home
Product Category
analytical chemistry
Reference substance
Cyclopentanecarboxylic acid, 3-[(1R)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-rel-
Cyclopentanecarboxylic acid, 3-[(1R)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-rel- -
Names and Identifiers
Name
Peramivir Impurity 6
Synonyms
Peramivir Impurity 6
Peramivir impurities10
(1S,2S,3R,4R)-3-((R)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid
Cyclopentanecarboxylic acid, 3-[(1R)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-rel-
CAS
2124296-37-1
Cyclopentanecarboxylic acid, 3-[(1R)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-rel- -
Physico-chemical Properties
Molecular Formula
C15H28N4O4
Molar Mass
328.41
Density
1.39±0.1 g/cm3(Predicted)
pKa
4.08±0.70(Predicted)
View Cyclopentanecarboxylic acid, 3-[(1R)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-rel- structural formula
Supplier List
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Spot supply
Product Name:
Peramivir Impurity 102
Visit Supplier Webpage
Request for quotation
CAS: 2124296-37-1
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Spot supply
Product Name:
Peramivir Impurity 102
Visit Supplier Webpage
Request for quotation
CAS: 2124296-37-1
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
View History
Cyclopentanecarboxylic acid, 3-[(1R)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-rel-
Home
Product Category
© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001